Our novel Cas nucleases enable genome editing results that might not be possible with other Cas nucleases.
Newly discovered CRISPR-Cas systems are strong candidates for genome editing due to their small size and unique PAM (protospacer adjacent motif) requirements. Using our protein discovery workflow, we have and continue to identify variants with flexibility to cut single or double-stranded DNA or RNA or to be used with novel DNA or RNA modifying modalities.